trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Creatine supplementation promotes cancer growth in humans.

the verdict
CONTESTED PARTIAL
Recorded sources
2 sources for · 3 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that creatine supplementation promotes cancer growth in humans?

Partly. Evidence is mixed and only partial: one 2026 study reports creatine supplementation promoted tumor metastasis in mouse models and hyperactive platelets in healthy volunteers, while a 2015 human crossover study found no increase in carcinogenic heterocyclic amines and mouse immunotherapy work found creatine enhanced antitumor efficacy. None of the retrieved items directly establishes that creatine promotes primary cancer growth in humans.

Verdict: CONTESTED PARTIAL · 2 sources for, 3 against · Last checked

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Evidence for · 2
2026
Get citation
S, X., R, C., X, S., X, N., Y, W., L, C., Y, C., S, L., M, R., L, C., Y, L., Y, X., M, C., D, Z., S, Z., L, Y., W, L., J, Z., & Y, Y. (2026). Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.. doi.org. https://doi.org/10.1038/s41467-026-74639-z

Evidence against · 3
Get citation
Can creatine supplementation form carcinogenic heterocyclic amines in humans? - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.1113/JP270861

See more details
More for · 1
Get citation
Frontiers | The association between dietary creatine intake and cancer in U.S. adults: insights from NHANES 2007–2018. (n.d.). frontiersin.org. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1460057/full

More against · 2
2025
Get citation
In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes. (2025). doi.org. https://doi.org/10.1158/2326-6066.cir-24-0834

2025
Get citation
Data from <i>In Situ</i> Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes. (2025). doi.org. https://doi.org/10.1158/2326-6066.c.7856546

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work